Denmark· DK-28106638421
Levosimendan "EQL Pharma"
A levosimendan product containing levosimendan, registered in Denmark by EQL Pharma AB. The same ATC class is registered in 14 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Levosimendan is registered in 14 of 19 countries.
Countries holding a registration under ATC C01CX08 (levosimendan), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Levosimendan · ATC C01CX08
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- LEVOSIMENDAN
- Manufacturer
- EQL Pharma AB
- Country
- Denmark (DK)
- ATC code
- C01CX08
- ATC class
- Levosimendan
- Defined daily dose
- 11 mg, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106638421
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under C01CX08
Levosimendan, as other registers publish it.
- DenmarkLevosimendan "Amdipharm"Amdipharm Limited
- DenmarkLevosimendan "Bioglan"Bioglan AB
- DenmarkLevosimendan "Carinopharm"Carinopharm GmbH
- DenmarkLevosimendan "Farmak"Farmak International Sp. z o.o.
- DenmarkLevosimendan "Fresenius Kabi"Fresenius Kabi AB
- DenmarkLevosimendan "Stada"STADA Arzneimittel AG
- DenmarkLevosimendan "Tillomed"Tillomed Pharma GmbH
- DenmarkLevosimendan "Waymade"Waymade B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/507e058e-28eb-40fd-ad64-f380fa4734c2 GET /v1/drugs/507e058e-28eb-40fd-ad64-f380fa4734c2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "koncentrat til infusionsvæske, opløsning",
"source": "dkma",
"strength": "2,5 mg/ml",
"auth_role": "CMS",
"dk_drugid": "28106638421",
"substance": "LEVOSIMENDAN",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": false,
"registration_date_serial": "45139"
}See everything about levosimendan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.